Identifying the optimal crystal form is a critical step in drug development, directly influencing a drug’s solubility, stability, and overall efficacy. Yet, traditional methods—relying on manual trial-and-error—are often slow and costly, hindering progress and increasing risk.
To solve this problem, we have built the XtalGazer™ Crystal Structure Prediction (CSP) platform. Powered by advanced AI, XtalGazer™CSP delivers rapid and accurate crystal structure predictions, helping you find the optimal polymorph faster and more reliably than ever before. Its intuitive interface allows scientists of all technical backgrounds to easily generate and analyze results. With real-time processing and AI-driven calculations, you can streamline your workflows, reduce costs, and boost the efficiency of your drug development process.
👉 Watch our video below to see how our platform can revolutionize your approach to polymorph screening.
